Multidrug resistance: Clinical relevance in haematological malignancies
- 31 March 1991
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 5 (1) , 38-41
- https://doi.org/10.1016/0268-960x(91)90006-x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Inherent adriamycin resistance in a murine tumour line: circumvention with verapamil and norverapamilBritish Journal of Cancer, 1989
- Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.Journal of Clinical Oncology, 1989
- Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein.Journal of Histochemistry & Cytochemistry, 1989
- Expression of Multidrug Resistance Gene in Human CancersJNCI Journal of the National Cancer Institute, 1989
- The multidrug resistance phenotypeBritish Journal of Cancer, 1988
- DETECTION OF A MULTIDRUG RESISTANT PHENOTYPE IN ACUTE NON-LYMPHOBLASTIC LEUKAEMIAThe Lancet, 1987
- The effect of verapamil on the pharmacokinetics of adriamycinCancer Chemotherapy and Pharmacology, 1986
- Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistanceNature, 1986
- The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humansAmerican Heart Journal, 1985
- Cell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell LinesScience, 1983